Have Insiders Been Buying Alligator Bioscience AB (publ) (STO:ATORX) Shares?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is that there are more than a few examples of insiders dumping stock prior to a period of weak performance. So shareholders might well want to know whether insiders have been buying or selling shares in Alligator Bioscience AB (publ) (STO:ATORX).

What Is Insider Buying?

It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, rules govern insider transactions, and certain disclosures are required.

We don’t think shareholders should simply follow insider transactions. But logic dictates you should pay some attention to whether insiders are buying or selling shares. For example, a Columbia University study found that ‘insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers’.

View our latest analysis for Alligator Bioscience

The Last 12 Months Of Insider Transactions At Alligator Bioscience

There wasn’t any very large single transaction over the last year, but we can still observe some trading.

Happily, we note that in the last year insiders bought 11400 shares for a total of kr253k. While Alligator Bioscience insiders bought shares last year, they didn’t sell. You can see a visual depiction of insider transactions (by individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

OM:ATORX Recent Insider Trading, June 14th 2019
OM:ATORX Recent Insider Trading, June 14th 2019

Alligator Bioscience is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Insider Ownership of Alligator Bioscience

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 18% of Alligator Bioscience shares, worth about kr339m. We’ve certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

So What Do The Alligator Bioscience Insider Transactions Indicate?

It doesn’t really mean much that no insider has traded Alligator Bioscience shares in the last quarter. However, our analysis of transactions over the last year is heartening. It would be great to see more insider buying, but overall it seems like Alligator Bioscience insiders are reasonably well aligned (owning significant chunk of the company’s shares) and optimistic for the future. Of course, the future is what matters most. So if you are interested in Alligator Bioscience, you should check out this free report on analyst forecasts for the company.

But note: Alligator Bioscience may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.